Higer Bus Launches European Parts and Service CenterHiger Bus has officially opened its first European Parts Center and ...
Read More
Higer Bus Launches European Parts and Service CenterHiger Bus has officially opened its first European Parts Center and ...
Read More
King Street Welcomes Michael Fuller as Managing DirectorKing Street Capital Management, a prominent global alternative i...
Read More
Embarking on a Cultural Journey with Dennis Quaid Prepare to broaden your horizons with the insightful segment of "Viewp...
Read More
Hankook Tire Excels at WRC Secto Rally Finland In an electrifying display of speed and precision, Hankook Tire showcased...
Read More
Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief Raytone Biotech, a clinical-stage biotechnology company...
Read More
A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....
Continue Reading
A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...
Continue Reading
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...
Continue Reading
A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
Clariant Adjusts Its Sales Projections In recent trading, shares of Clariant (SIX: CLN) experienced a decline exceeding 5% as the Swiss chemicals giant updated its annual sales forecasts and announced third-quarter profits that fell short of market expectations. This adjustment raises questions about the current state of the chemical industry and Clariant's positioning...
Continue Reading
The Surge in Vehicle Electrification: A Market Overview The global Vehicle Electrification Market is set to witness remarkable growth, forecasted to expand from USD 51.84 billion to USD 83.87 billion by 2032, achieving a compound annual growth rate (CAGR) of 7.1%. As the world shifts towards sustainable mobility, electrification in vehicles is accelerating, transforming...
Continue Reading
New Research Reveals Benefits of Grain Foods Recent studies have shed light on the vital role that grain foods play in achieving healthier diet patterns and metabolic health. This research highlights that a variety of grain foods can significantly contribute to improved nutrition, leading to better health outcomes for individuals. Grain foods, whether whole or refined,...
Continue Reading
Lands' End Updates Financial Outlook Following Revenue Changes Lands’ End, Inc. (NASDAQ: LE) has seen its stock rise after the company announced its second-quarter earnings. While it faced some revenue challenges, it reported net revenue of $317.2 million, exceeding analyst predictions of $307.41 million. Overview of Quarterly Performance The adjusted loss per share was...
Continue Reading
Current Trends in Housing Affordability in California As of mid-2025, 15% of households in California can afford a median-priced home costing $905,680. This figure dropped from 17% in the previous quarter but showed improvement from 14% the same time last year. The Traditional Housing Affordability Index (HAI) indicates persistent affordability challenges for potential...
Continue Reading